CliffBio

Agios Pharmaceuticals

Patent cliffs & loss of exclusivity

Agios Pharmaceuticals is a public American pharmaceutical company

Company

AngelList URLhttps://angel.co/agios-pharmaceuticals
CAGE Code86WZ9
Legal NameAgios Pharmaceuticals, Inc.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/agios-pharmaceuticals
Facebook URLhttps://www.facebook.com/pages/Agios-Pharmaceuticals/106390412737494
Full Address88 Sidney Street, Cambridge, MA 02139, US
Legal Entity Identifier529900ONJHY8EOGYT555

4 upcoming patent cliffs

DrugIngredientTypeCliff
  1. AQVESMEMITAPIVAT SULFATESmall mol.Jul 2041
  2. PYRUKYNDMITAPIVAT SULFATESmall mol.Jul 2041
  3. PYRUKYNDMITAPIVAT SULFATESmall mol.Jul 2041
  4. PYRUKYNDMITAPIVAT SULFATESmall mol.Jul 2041

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Agios Pharmaceuticals — patent cliffs & loss of exclusivity | CliffBio